Prescription Drug Prices Drop 3.1% as Politics Over Credit Intensify

U.S. prescription drug prices fell by 3.1 percent over the 12 months ending in July 2026, marking the steepest year-over-year decline since 1963, according to federal data released last week. The Bureau of Labor Statistics reported that the drop was part of a broader decrease in medicinal drug prices, which fell 2.7 percent annually. The White House immediately claimed the decline as a direct result of President Donald Trump's policies, while drug pricing experts emphasized a more complex set of contributing factors.

The administration highlighted the "Most Favored Nation" agreements it secured with 17 major pharmaceutical companies, designed to align U.S. prices with those paid by comparable developed nations. A White House statement asserted that President Trump is the first president to lower prescription drug prices, calling the data a reflection of bold action. The president himself touted the figures on social media, asking, "What else do I have to say?"

However, several healthcare policy experts pointed to additional, and potentially more significant, drivers of the price reduction. They cited the ongoing impact of the Inflation Reduction Act of 2022, passed under...